Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers
Alphabet's Verily, Mayo Clinic team up on decision support tech for cardiovascular care
FDA greenlights first smartphone-based home COVID-19 test
Pfizer, BioNTech sign on with Eurofarma of Brazil for COVID-19 vaccine production
AstraZeneca, rHealth develop fingerstick test for low platelet count, a rare side effect of AZ's COVID vaccine
Cigna to expand ACA exchange footprint to 3 new states, 93 counties
GSK's latest meningitis B campaign taps first spokescelebrity: 'Punky Brewster,' now mom of 4
ACOs generated $4.1B in gross savings in 2020, nearly double 2019 amount
Unraveling the link between migraines and protection against diabetes
Trinity Health Mid-Atlantic teams with NeuroFlow to offer mental health app to workers
COVID-19 tracker: FDA awards nod to first smartphone-based home test; COVAX kicks off Sinopharm, Sinovac shipments

Featured Story

Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers

By Angus Liu

Gilead Sciences and Bristol Myers Squibb aren’t just fighting the CAR-T war in the clinic around their efficacy but also in court over patents. The latest winner? Gilead.

Alphabet's Verily, Mayo Clinic team up on decision support tech for cardiovascular care

By Heather Landi

Alphabet's Verily continues to push further into clinical care and is using its tech muscle to build advanced decision support tools for providers. Teaming up with Mayo Clinic, Verily will pull in the hospital's clinical content and apply advanced clinical analytics and user-centered design to deliver care insights with an initial focus on cardiovascular and cardiometabolic conditions.

FDA greenlights first smartphone-based home COVID-19 test

By Conor Hale

Developed by BD in collaboration with Scanwell Health, the Veritor rapid antigen test operates similar to a home pregnancy test, at first.

Pfizer, BioNTech sign on with Eurofarma of Brazil for COVID-19 vaccine production

By Kevin Dunleavy

Eurofarma of Brazil will perform fill-finish of the Pfizer-BioNTech COVID-19 vaccine for distribution in Latin America. The agreement will provide for the supply of more than 100 million doses annually.

AstraZeneca, rHealth develop fingerstick test for low platelet count, a rare side effect of AZ's COVID vaccine

By Andrea Park

The chances of developing thrombocytopenia after receiving AstraZeneca's COVID-19 vaccine may be slim, but in an apparent effort to address the issue head-on, the pharma company teamed up with rHealth to develop a diagnostic test that could measure platelet count at the point of care.

Cigna to expand ACA exchange footprint to 3 new states, 93 counties

By Paige Minemyer

Cigna is planning to expand its footprint on the Affordable Care Act's exchanges into three new states and 93 new counties for the 2022 plan year, the insurer announced Thursday.

GSK's latest meningitis B campaign taps first spokescelebrity: 'Punky Brewster,' now mom of 4

By Beth Snyder Bulik

Back to school often means meningitis awareness campaigns, but this year GlaxoSmithKline is drawing a distinction between the more common MenACWY vaccine for adolescents and the separate MenB shot for older teens in the U.S.

ACOs generated $4.1B in gross savings in 2020, nearly double 2019 amount

By Robert King

Accountable care organizations generated $4.1 billion in gross savings for Medicare in 2020, nearly double the $2.6 billion they posted in 2019, new CMS data shows.

Unraveling the link between migraines and protection against diabetes

By Kyle LaHucik

University of Tennessee researchers found that the peptides behind migraine pain can trigger insulin production in mice, and the study could lead to better methods for preventing or treating diabetes.

Trinity Health Mid-Atlantic teams with NeuroFlow to offer mental health app to workers

By Anastassia Gliadkovskaya

Independence Blue Cross Foundation is teaming up with Trinity Health Mid-Atlantic and mental health tech company NeuroFlow to support its health workers’ mental health.

COVID-19 tracker: FDA awards nod to first smartphone-based home test; COVAX kicks off Sinopharm, Sinovac shipments

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The FDA has awarded its first nod for at-home COVID-19 test from BD and Scanwell Health's, which delivers results through a user's smartphone. The global vaccine sharing program COVAX will ship out its first doses of Sinopharm and Sinovac vaccines despite concerns over their effectiveness, Reuters reports. Plus more headlines.

PM Tracker